# Nexttobe

Nexttobe is a Private Equity based in Uppsala, Sweden.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Uppsala, Sweden
- **Region:** Europe
- **Address:** Uppsala, Sweden
- **Founded:** 2011
- **Assets under management:** Undisclosed
- **Website:** www.nxt2b.com
- **LinkedIn:** https://linkedin.com/company/nexttobe-ab

## Regulatory record

- **Reports private funds:** No

## About

NXT2B is a fully privately owned venture capital company that does not require external capital and can make fast investment decisions. It focuses on growth equity investments in healthcare, medical devices and specialty pharmaceutical companies, and also invests in technology and consumer companies. Since starting in 2011 it has invested in more than 30 companies and supports portfolio management teams through active ownership.

## Sectors

- Digital Health
- Healthcare Services

## People

- Erika Kjellberg Eriksson — CEO and Chair of the Board
- Per-Olof Wallström — Member of the Board
- Angelica Loskog — Scientific adviser

## Questions

### Who runs investment decisions at Nexttobe?

CEO and Chair Erika Kjellberg Eriksson leads the firm. She built her career as CFO of OxThera, Vice President and CFO of Q-Med, and CFO and CEO of BioPhausia before moving into venture leadership. Board member Per-Olof Wallström and scientific adviser Angelica Loskog provide deal-evaluation support, with Loskog bringing hands-on immunotherapy research directly from Uppsala University and portfolio company Lokon Pharma.

### How is Nexttobe funded?

The firm is fully privately owned and self-capitalized. It does not solicit external LP commitments, which it says lets the team make faster decisions than a traditional venture fund. The source of the proprietary capital has not been publicly disclosed.

### Does Nexttobe participate in fund commitments or only direct deals?

Nexttobe only makes direct equity investments. It does not invest as a limited partner in other venture funds or private equity vehicles. The firm takes active ownership positions and works alongside management teams to commercialize the underlying businesses.

### What investment stages does Nexttobe target?

The firm focuses on early-phase projects with high scientific quality, spanning venture and growth equity. It emphasizes healthcare, medical devices, and specialty pharmaceuticals, while remaining open to technology and consumer companies when the idea is unique. The 30-plus portfolio includes both startups and more developed platforms like Hansa Biopharma and Q-linea.

## Related profiles

- [Next Tier Ventures](https://altss.com/profile/next-tier-ventures)
- [NextUp](https://altss.com/profile/nextup)

---

Last updated: 2026-08-11T15:07:34.613Z

Canonical page: https://altss.com/profile/nexttobe-ab

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology